IMpower110: Phase III Trial Comparing 1L Atezolizumab with Chemotherapy in PD-L1 Selected Chemotherapy-Naive NSCLC Patients
JOURNAL OF THORACIC ONCOLOGY(2017)
关键词
NSCLC,clinical trials,atezolizumab,Immunotherapy
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要